Non-small-cell lung cancer and Ba/F3 transformed cells harboring the ERBB2 G776insV_G/C mutation are sensitive to the dual-specific epidermal growth factor receptor and ERBB2 inhibitor HKI-272. (Q40259915)
Jump to navigation
Jump to search
scientific article published on July 2006
- Non-small-cell lung cancer and Ba/F3 transformed cells harboring the ERBB2 G776insV_G/C mutation are sensitive to the dual-specific epidermal growth factor receptor and ERBB2 inhibitor HKI-272
Language | Label | Description | Also known as |
---|---|---|---|
English | Non-small-cell lung cancer and Ba/F3 transformed cells harboring the ERBB2 G776insV_G/C mutation are sensitive to the dual-specific epidermal growth factor receptor and ERBB2 inhibitor HKI-272. |
scientific article published on July 2006 |
|
Statements
1 reference
Non-small-cell lung cancer and Ba/F3 transformed cells harboring the ERBB2 G776insV_G/C mutation are sensitive to the dual-specific epidermal growth factor receptor and ERBB2 inhibitor HKI-272. (English)
1 reference
Heidi Greulich
1 reference
Matthew Meyerson
1 reference
Takeshi Shimamura
1 reference
Hongbin Ji
1 reference
Yuko Minami
1 reference
Roman K Thomas
1 reference
April M Lowell
1 reference
Kinjal Shah
1 reference
Karen A Glatt
1 reference
Geoffrey I Shapiro
1 reference
Kwok-Kin Wong
1 reference
1 July 2006
1 reference
1 reference
Identifiers
1 reference